medigraphic.com
ISSN 1561-2929 (Print)

2019, Number S1-2

<< Back Next >>

RCAN 2019; 29 (S1-2)

Marco teórico de la presente investigación

Language: Spanish
References: 32
Page: S17-S33
PDF size: 226.84 Kb.


Text Extraction

No Abstract.


REFERENCES

  1. Jha V, Garcia-Garcia G, Iseki K, Li Z, Naicker S, Plattner B; et al. Chronic kidney disease: Global dimension and perspectives. The Lancet 2013;382(9888):260-72.

  2. Liyanage T, Ninomiya T, Jha V, Neal B, Patrice HM, Okpechi I; et al. Worldwide access to treatment for end-stage kidney disease: A systematic review. The Lancet 2015;385(9981): 1975-82.

  3. Cusumano AM, Garcia-Garcia G, Gonzalez-Bedat MC, Marinovich S, Lugon J, Poblete- Badal H; et al. Latin American Dialysis and Transplant Registry: 2008 prevalence and incidence of end-stage renal disease and correlation with socioeconomic indexes. Kidney Int Suppl 2013;3:153-6.

  4. Pérez-Oliva JF. Current status of renal replacement therapy in Cuba 2006. Ethn Dis 2009; 19(1 Suppl 1):S1-S1. Disponible en: https://ethndis.org/priorsuparchives/ethn-19-01s1- 10.pdf. Fecha de última visita: 7 de Febrero del 2019.

  5. Almaguer M, Herrera R, Alfonzo J, Magrans C, Mañalich R, Martinez A; et al. Chronic kidney disease in Cuba: Epidemiological studies, integral medical care, and strategies for prevention. Ren Fail 2006;28:671-6.

  6. Wallace MA. Anatomy and physiology of the kidney. AORN J 1998;68:799-820.

  7. Levey AS, Coresh J. Chronic kidney disease. The Lancet 2012;379(9811):165-80.

  8. Raff AC, Meyer TW, Hostetter TH. New insights into uremic toxicity. Curr Op Nephrol Hypertens 2008;17:560-5.

  9. Ito S, Yoshida M. Protein-bound uremic toxins: New culprits of cardiovascular events in chronic kidney disease patients. Toxins 2014;6(2):665-78.

  10. Moe SM, Drüeke T, Lameire N, Eknoyan G. Chronic kidney disease-mineral-bone disorder: A new paradigm. Adv Chron Kid Dis 2007;14:3-12.

  11. Alcázar RA. Electrolyte and acid-base balance disorders in advanced chronic kidney disease. Nefrologia [España] 2008;28:87-93.

  12. Massy ZA, Stenvinkel P, Drueke TB. Progress in uremic toxin research: The role of oxidative stress in chronic kidney disease. Semin Dial 2009;22:405-8.

  13. McClellan W, Aronoff SL, Bolton WK, Hood S, Lorber DL, Tang KL; et al. The prevalence of anemia in patients with chronic kidney disease. Curr Med Res Op 2004;20:1501-10.

  14. Fouque D, Pelletier S, Mafra D, Chauveau P. Nutrition and chronic kidney disease. Kidney Int 2011;80:348-57.

  15. Goraya N, Wesson DE. Dietary management of chronic kidney disease: Protein restriction and beyond. Curr Op Nephrol Hypertens 2012;21:635-40.

  16. Johnson DW. Dietary protein restriction as a treatment for slowing chronic kidney disease progression: The case against. Nephrology 2006;11:58-62.

  17. Chanard J, Lavaud S, Randoux C, Rieu P. New insights in dialysis membrane biocompatibility: Relevance of adsorption properties and heparin binding. Nephrol Dial Transpl 2003;18:252-7.

  18. Dukkipati R, Noori N, Feroze U, Kopple JD. Dietary protein intake in patients with advanced chronic kidney disease and on dialysis. Semin Dial 2010;23:365-72.

  19. Avesani CM, Kamimura MA, Cuppari L. Energy expenditure in chronic kidney disease patients. J Ren Nutr 2011;21:27-30.

  20. Huang MC, Chen ME, Hung HC, Chen HC, Chang WT, Lee CH; et al. Inadequate energy and excess protein intakes may be associated with worsening renal function in chronic kidney disease. J Ren Nutr 2008;18:187-94.

  21. Wang XH, Mitch WE. Mechanisms of muscle wasting in chronic kidney disease. Nature Rev Nephrol 2014;10:504-16.

  22. Rajan VR, Mitch WE. Muscle wasting in chronic kidney disease: The role of the ubiquitin proteasome system and its clinical impact. Pediatr Nephrol 2008;23:527-35.

  23. Campbell KL, Ash S, Bauer J, Davies PS. Critical review of nutrition assessment tools to measure malnutrition in chronic kidney disease. Nutr Diet 2007;64:23-30.

  24. Kyle UG, Bosaeus I, De Lorenzo AD, Deurenberg P, Elia M, Gómez JM; et al. Bioelectrical impedance analysis- Part I: Review of principles and methods. Clin Nutr 2004;23:1226-43.

  25. Kyle UG, Bosaeus I, De Lorenzo AD, Deurenberg P, Elia M, Gómez JM; et al. Bioelectrical impedance analysis- Part II: Utilization in clinical practice. Clin Nutr 2004;23:1430-53.

  26. Fricke H. The theory of electrolytic polarization. Phil Mag 1932;7(14):107-22.

  27. Cole KS, Cole RH. Dispersion and absorption in dielectrics. I. Alternating current characteristics. J Chem Phys 1941;9:341-51.

  28. Cole KS. Membranes, ions and impulses: A chapter of classical Biophysics. University of California Press. Berkley [CA]: 1972.

  29. Matthie J, Zarowitz B, De Lorenzo A, Andreoli A, Katzarski K, Pan G, Withers P. Analytic assessment of the various bioimpedance methods used to estimate body water. J Appl Physiol 1998;84:1801-16.

  30. Pichard C, Kyle UG, Bracco D, Slosman DO, Morabia A, Schutz Y. Reference values of fatfree and fat masses by bioelectrical impedance analysis in 3393 healthy subjects. Nutrition 2000;16:245-54.

  31. Lara Lafargue A, Bergues Cabrales L, Morales Larramendi R. Bioelectrical parameters of the whole human body obtained through bioelectrical impedance analysis. Bioelectromagnetics 2002;23:450-4.

  32. Lexa Nescolarde AN, Bogónez-Franco P, Lara A, Vaillant G, Morales R, Rosell-Ferrer J. Reference values of the bioimpedance vector components in a Caribbean population. e-SPEN J 2013:0-0. Disponible en: https://www.sciencedirect.com/science/article/pii/S2212826313000298. Fecha de última visita: 6 de Febrero del 2019.




2020     |     www.medigraphic.com